Covid-19 « Science and Enterprise

Infographic – More US Support for Childhood Vaccines Than Covid-19

By Alan, on May 27th, 2023%

Bar charts: U.S. opinion on MMR and Covid-19 vaccines

A recent poll shows U.S. adults continue to favor vaccinations against the childhood diseases mumps, measles, and rubella, but show less support for Covid-19 vaccines. . . . → Read More: Infographic – More US Support for Childhood Vaccines Than Covid-19

Low-Dose Covid-19 Vaccine Generates Strong Immune Response

By Alan, on April 27th, 2023%

Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses. . . . → Read More: Low-Dose Covid-19 Vaccine Generates Strong Immune Response

Biotech Gains $53.7M Infectious Disease Test Award

By Alan, on April 21st, 2023%

A maker of diagnostics for infectious diseases is receiving a $53.7 million contract to develop and validate reliable home molecular tests for Covid-19 and flu infections. . . . → Read More: Biotech Gains $53.7M Infectious Disease Test Award

Self-Applied Patch Shown Feasible for Vaccine Delivery

By Alan, on March 31st, 2023%

A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians. . . . → Read More: Self-Applied Patch Shown Feasible for Vaccine Delivery

Chewable Covid-19 Drug Reduces Viral Load, Symptoms

By Alan, on March 29th, 2023%

Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease. . . . → Read More: Chewable Covid-19 Drug Reduces Viral Load, Symptoms

Home Infectious Disease Diagnostic Begins Clinical Tests

By Alan, on February 22nd, 2023%

A company offering DNA analysis tests to detect infectious diseases at home and point-of-care is beginning clinical evaluations of its technology. . . . → Read More: Home Infectious Disease Diagnostic Begins Clinical Tests

Nasal Spray Reduces Flu Duration in Challenge Trial

By Alan, on February 13th, 2023%

An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus. . . . → Read More: Nasal Spray Reduces Flu Duration in Challenge Trial

Light-Activated Treatment Kills Covid-19 Nasal Viruses

By Alan, on January 31st, 2023%

Clinical trial findings show a light-activated disinfectant process kills SARS-CoV-2 viruses in the nose causing Covid-19 infections without harming nasal tissue. . . . → Read More: Light-Activated Treatment Kills Covid-19 Nasal Viruses

CEPI Assessing Advanced RNA Nanoparticle Vaccine

By Alan, on January 12th, 2023%

An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine

Trial Shows Anti-Inflammatory Drug Stops Covid-19 Hospitalization

By Alan, on January 3rd, 2023%

Findings from a clinical trial show an anti-inflammatory drug reduces new symptoms among people with Covid-19 infections and keeps them out of the hospital. . . . → Read More: Trial Shows Anti-Inflammatory Drug Stops Covid-19 Hospitalization

Subscribe for email alerts

Donate to Science & Enterprise

Like us on Facebook

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Specials

Guest Posts

Please share Science & Enterprise